Citadel Advisors LLC Takes Position in Rapid Micro Biosystems, Inc. (NASDAQ:RPID)

Citadel Advisors LLC bought a new stake in Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 72,024 shares of the company's stock, valued at approximately $65,000. Citadel Advisors LLC owned approximately 0.17% of Rapid Micro Biosystems as of its most recent filing with the SEC.

Separately, Renaissance Technologies LLC increased its holdings in shares of Rapid Micro Biosystems by 122.9% during the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock worth $165,000 after buying an additional 100,942 shares in the last quarter. 52.60% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, KeyCorp began coverage on Rapid Micro Biosystems in a report on Wednesday, February 12th. They set an "overweight" rating and a $8.00 price objective on the stock.

Rapid Micro Biosystems Trading Down 1.9%

RPID stock traded down $0.07 during trading on Thursday, hitting $3.69. The company had a trading volume of 19,710 shares, compared to its average volume of 192,429. Rapid Micro Biosystems, Inc. has a one year low of $0.58 and a one year high of $4.04. The business has a 50-day moving average of $2.77 and a 200-day moving average of $2.20. The stock has a market cap of $161.74 million, a PE ratio of -3.29 and a beta of 1.33.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last issued its earnings results on Friday, May 9th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.01. The company had revenue of $7.21 million during the quarter, compared to the consensus estimate of $6.63 million. Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. Research analysts forecast that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current year.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.